Scout | Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)

This opportunity is no longer accepting applications.

grant

Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)

This grant opportunity, a reissue of PAR-19-147, aims to fund research in developing new compounds to prevent and treat nervous system disorders. It seeks to encourage work in identifying, designing, and testing potential therapeutic compounds, improving their chemical activity, enhancing their effectiveness and pharmacokinetics, and analyzing their metabolism and pharmacokinetics. The focus i…

Source

Agency: National Institutes of Health

Sub-agency: National Institute of Mental Health

Program: SBIR

Dates

Opportunity Released: November 29, 2021

Open for Submission: November 29, 2021

Submission Deadline: January 7, 2025

Application Window Closes: January 7, 2025

Keywords

nervous system disorders

novel compounds

preclinical testing

therapeutics discovery

hit-to-lead chemistry

lead optimization

drug metabolism

pharmacokinetics

NIMH

NIA

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers